Entries by

WhiteSwell Expands Leadership Team with Key Appointments

New vice president of clinical affairs and board of directors member will support advancement of eLym™ System therapy for acute decompensated heart failure GALWAY, Ireland — September 5, 2024 — WhiteSwell, a company pioneering a new paradigm in the treatment of acute decompensated heart failure (ADHF), today announced the appointments of Ric Cote to its […]

Device to treat acute decompensated heart failure feasible, safe in first-in-human study
(Cardiology Today)

https://www.healio.com/news/cardiology/20240320/device-to-treat-acute-decompensated-heart-failure-feasible-safe-in-firstinhuman-study Key takeaways: Device-based thoracic duct decompression reduced congestion safely in patients with acute decompensated heart failure. The device targets congestion from the interstitial space, which diuretics mostly do not. Among patients with acute decompensated heart failure, device-based thoracic duct decompression demonstrated the ability to reduce congestion safely, according to results of a first-in-human study. […]

WhiteSwell Announces Six-Month Outcomes After eLym System Treatment for Acute Decompensated Heart Failure Patients in its DELTA-HF Study

Patients were rehospitalized for heart failure less frequently in the six months following therapy GALWAY, Ireland — 6 March 2024 — WhiteSwell, a company pioneering a new paradigm in the treatment of acute decompensated heart failure (ADHF), announced today positive six-month follow-up data on the initial nine patients treated in its ongoing DELTA-HF trial evaluating […]

WhiteSwell Announces Successful Treatment of Acute Decompensated Heart Failure Patients in its Early Feasibility DELTA-HF Study


GALWAY, Ireland – 7 October 2023 – WhiteSwell, a company pioneering a new paradigm in the treatment of acute decompensated heart failure (ADHF), announced today positive initial results from its ongoing DELTA-HF trial evaluating the WhiteSwell eLym™ System. The data were presented at the Heart Failure Society of America (HFSA) Annual Scientific Meeting 2023 in […]